Previous Article | Next Article 
J Virol, June 1998, p. 4950-4955, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
L* Protein of the DA Strain of Theiler's Murine
Encephalomyelitis Virus Is Important for Virus Growth in a Murine
Macrophage-Like Cell Line
Hisashi
Takata,1
Masatsugu
Obuchi,2
Jiro
Yamamoto,1
Takato
Odagiri,2
Raymond P.
Roos,3
Hideaki
Iizuka,1 and
Yoshiro
Ohara2,*
Departments of
Neurosurgery1 and
Microbiology,2 Kanazawa Medical
University, Uchinada, Ishikawa 920-0293, Japan, and
Department of Neurology, University of Chicago, Chicago,
Illinois 606373
Received 23 October 1997/Accepted 22 February 1998
 |
ABSTRACT |
Strain GDVII and other members of the GDVII subgroup of Theiler's
murine encephalomyelitis virus (TMEV) are highly virulent and cause
acute polioencephalomyelitis in mice. Neither viral persistence nor
demyelination is demonstrated in the few surviving mice. On the other
hand, strain DA and other members of the TO subgroup of TMEV are less
virulent and establish a persistent infection in the spinal cord, which
results in a demyelinating disease. We previously reported that GDVII
does not actively replicate in a murine macrophage-like cell line,
J774-1, whereas DA strain productively infects these cells (M. Obuchi,
Y. Ohara, T. Takegami, T. Murayama, H. Takada, and H. Iizuka, J. Virol. 71:729-733, 1997). In the present study, we used recombinant
viruses between these strains of the two subgroups to demonstrate that
the DA L coding region of DA strain is important for virus growth in
J774-1 cells. Additional experiments with a mutant virus indicate that
L* protein, which is synthesized out of frame with the polyprotein from
an additional alternative initiation codon in the L coding region of TO
subgroup strains, is a key determinant responsible for the cell-type-specific restriction of virus growth. L* protein may play a
critical role in the DA-induced restricted demyelinating infection by
allowing growth in macrophages, a major site for virus persistence.
 |
INTRODUCTION |
Theiler's murine encephalomyelitis
virus (TMEV) includes a number of murine picornavirus strains that are
divided into two subgroups on the basis of their different biological
activities. Strain GDVII and other members of the GDVII subgroup
produce acute fatal polioencephalomyelitis in mice. In the few
surviving mice, no virus persistence is observed (10). In
contrast, strain DA and other members of the TO subgroup persistently
infect the spinal cord, resulting in demyelination. The white matter
disease caused by TO subgroup strains is an excellent experimental
model of the human demyelinating disease multiple sclerosis
(15). The precise mechanisms of viral persistence and
demyelination of TO subgroup strains remain poorly understood.
Macrophages may be a critical cell in the TMEV-induced demyelinating
disease. Studies suggest that the virus persists primarily in
macrophages (1, 5, 9, 12) and that virus persistence is
required for TMEV-induced demyelination (2, 11). Macrophages persistently infected with TO subgroup strains may secrete cytokines or
other factors which induce myelin breakdown, resulting in
demyelination. In a previous study (14), we compared
infection of a murine macrophage-like cell line, J774-1, with two TMEV
subgroup strains. Strain GDVII did not actively replicate in J774-1
cells, whereas strain DA productively infected the cells. In the
present study, we compared the infection of intratypic recombinant and
mutant viruses in J774-1 cells to identify the molecular determinants responsible for TMEV growth in J774-1 cells. These findings may be
important in our understanding of virus replication and multiplication in macrophages and the pathogenesis of TMEV-induced demyelinating disease.
 |
MATERIALS AND METHODS |
Cells.
J774-1, an H-2d
macrophage-like cell line derived from a tumor of a female BALB/c
mouse, and BHK-21 cells, a baby hamster kidney-derived fibroblast cell
line permissive for TMEV infection, were maintained as previously
described (14).
Recombinant and mutant viruses.
A series of chimeric and
mutant cDNAs are shown in Fig. 1.
Chimeric cDNA clones constructed by replacing part of pDAFL3 with segments from pGDVIIFL2 as previously described (6, 18, 20) are named by first listing 5' and 3' junctions of the GDVII segment, then adding a slash, and finally adding DAFL3. pDAFL3 and pGDVIIFL2 are
wild-type full-length infectious cDNAs from strains DA and GDVII,
respectively (6, 18). pGD2C-3'/DAFL3 contains a segment of
pGDVIIFL2 from a StuI site at nucleotide (nt) 4843 in 2C to the 3' terminus. pGD1B-2C/DAFL3 contains a pGDVIIFL2 segment from an
NcoI site at nt 1964 in 1B to the same StuI site.
pGD1A-XhoI/DAFL3 contains a pGDVIIFL2 segment from a SauI
site at nt 1332 in 1A to a silent XhoI site, which was
engineered to leave a perfect P1/P2 junction following XhoI
digestion (20). pGD5'-XhoI/DAFL3 contains a pGDVIIFL2
segment from the 5' terminus to the same XhoI site.
pGDNC/DAFL3 contains a pGDVIIFL2 segment from an EcoRI site
at nt 280 to a KpnI site at nt 936. pDAFSSC was generated by
introducing six silent restriction enzyme cleavage sites into the
pDAFL3 leader (L) coding region (8). In pGDVIIL/DAFSSC, the
DA L coding region was substituted by GDVII L. pDAL*-1 has a mutation
of the AUG at nt 1079 to ACG, which is an alternative, out-of-frame,
initiation codon used for the synthesis of L* protein (7).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
A series of chimeric and mutant cDNAs generated to
delineate sequences responsible for virus growth in J774-1 cells. The
position of the TMEV coding area is shown at the top. The GDVII genome
and segments from it are shown as solid bars, and the DA genome is
shown as open bars. The asterisk indicates a point mutation of the L
coding region of pDAL*-1, changing the L* initiation AUG to ACG (but
not changing the coding region for the polyprotein).
|
|
Kinetics of virus growth.
The kinetics of the growth of the
recombinant and mutant viruses in J774-1 cells were examined as
previously described (14). A 35-mm-diameter plastic culture
dish containing 3 × 106 cells was infected at a
multiplicity of infection of 10 PFU per cell. The culture supernatants
and cell lysates were harvested at the indicated times and subjected to
titer determination by a standard plaque assay on BHK-21 cells.
Pulse-labeling experiment of viral and cellular proteins.
Radiolabeling of viral and cellular proteins was performed as
previously described (14). Briefly, 3 × 106 cells in a 35-mm-diameter plastic culture dish were
infected with each virus at a multiplicity of infection of 10 PFU per
cell and incubated in methionine-free medium. At the indicated times postinoculation (p.i.), the cells were pulse-labeled with 0.1 mCi of
L-[35S]methionine (1,000 Ci/mmol; Amersham)
per ml in methionine-free medium for 3 h. The cells were then
scraped off the dish and dissolved in sample buffer (0.01 M Tris-HCl
[pH 6.8], 1 mM EDTA, 2.5% sodium dodecyl sulfate, 5%
2-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue) after being
washed with phosphate-buffered saline. The cell lysates were analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in a 12%
polyacrylamide gel.
RNase protection assay.
To prepare the antisense probe for
mapping the 5' end of the viral RNA, pDAFL3 was cleaved at the
HincII site in the viral genome (nt 7783). The linearized
plasmid was transcribed in an in vitro transcription system with T3 RNA
polymerase (Stratagene, La Jolla, Calif.) in the presence of
[
-32P]UTP as described by the manufacturer. The
radiolabeled 362-nt RNA probe contained 310 nt of sequence
complementary to the 3' region of the viral genome and 52 nt of vector
sequence (16-18).
The RNase protection assay was performed with the RPA II RNase
protection assay kit (Ambion Inc., Austin, Tex.). Total RNA was
extracted and purified from 7 × 106 virus-infected
J774-1 cells by the guanidine thiocyanate method (4). A
10-µg portion of RNA and 100,000 cpm of 32P-labeled probe
were hybridized for 16 h at 42°C and treated with RNase solution
as specified by the manufacturer. The RNase-resistant fragments were
detected by electrophoresis on a 5% polyacrylamide gel containing 8 M
urea. The gels were dried and exposed to a type BAS-III imaging plate
(Fuji Photo Film Co., Ltd., Kanagawa, Japan) and analyzed with a Storm
860 bioimaging analyzer (Molecular Dynamics Japan, Tokyo, Japan).
 |
RESULTS |
Growth of recombinant viruses in J774-1 cells.
Since our
previous report (14) demonstrated that infectivity data
collected at 6 and 12 h p.i. reliably indicated whether a virus
grew in J774-1 cells, virus titers at these times were first examined.
Figure 2 shows the
infectivity titers following infection of J774-1 cells with five
recombinant viruses and the parental DA and GDVII viruses. As expected,
the 12-h-p.i. levels of cell-free and cell-associated DA virus were
more than 2 log units higher than the 6-h-p.i. levels. On the other
hand, the 12-h-p.i. levels of cell-free and cell-associated GDVII
viruses were lower than the 6-h-p.i. levels. For infection with
GD2C-3'/DAFL3, GD1B-2C/DAFL3, and GD1A-XhoI/DAFL3 recombinant viruses,
the levels of cell-free and cell-associated viruses were approximately
4 × 103 to 2 × 106 PFU/ml at 6 h p.i. and increased to 6 × 104 to 4 × 107 PFU/ml at 12 h p.i. The 12-h-p.i. levels were 1 to
3 log units higher than the 6-h-p.i. levels. These results indicated
growth of those recombinant viruses in J774-1 cells. In contrast, the levels of cell-free and cell-associated GD5'-XhoI/DAFL3 viruses were
approximately 2 × 104 PFU/ml at 6 h p.i. and
remained at a similar level at 12 h p.i., demonstrating that they
did not grow in J774-1 cells. The above results suggested that a
determinant(s) for virus growth in J774-1 cells was present in the 5'
untranslated region or the L coding region. To further narrow the
critical region, we infected J774-1 cells with GDNC/DAFL3 virus, which
contains most of the GDVII 5' untranslated region. The level of
cell-associated GDNC/DAFL3 virus increased from 5 × 104 PFU/ml at 6 h p.i. to approximately 7 × 106 PFU/ml at 12 h p.i. The level of cell-free
GDNC/DAFL3 virus at 6 h p.i. (1.5 × 104 PFU/ml)
increased only slightly at 12 h p.i. (2.4 × 104
PFU/ml); however, further studies indicated that the level of cell-free
virus increased to 3 × 106 PFU/ml at 24 h p.i.
(data not shown). In summary, virus growth occurred after infection
with GDNC/DAFL3, GD2C-3'/DAFL3, GD1B-2C/DAFL3, and GD1A-XhoI/DAFL3 but
not GD5'-XhoI/DAFL3, suggesting that the DA L coding region is
important for virus growth in J774-1 cells. To further clarify the
determinants critical for restriction of virus growth, experiments were
performed with GDVIIL/DAFSSC and DAL*-1 mutant viruses.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Growth of the parental and recombinant viruses in J774-1
cells. The culture supernatants (solid lines) and cell lysates (broken
lines) of infected J774-1 cells were harvested at 6 and 12 h p.i.
and subjected to titer determination by a standard plaque assay on
BHK-21 cells. Data are expressed as the mean of three independent
experiments. (a and g) parental DA and GDVII viruses, respectively; (b
to f) recombinants: GD2C-3'/DAFL3 (b), GD1B-2C/DAFL3 (c),
GD1A-XhoI/DAFL3 (d), GD5'-XhoI/DAFL3 (e), and GDNC/DAFL3 (f). Details
of the construction of these viruses are provided in Materials and
Methods and shown in Fig. 1.
|
|
Growth of GDVIIL/DAFSSC and DAL*-1 mutant viruses in BHK-21 and
J774-1 cells.
Since our previous study (14) showed that
the infection of TMEV in BHK-21 cells is different from that in J774-1
cells, the growth of GDVIIL/DAFSSC and DAL*-1 mutant viruses was
examined and compared following infection of BHK-21 and J774-1 cells at several time points (Fig. 3). In BHK-21
cells, infection with GDVIIL/DAFSSC and DAL*-1 mutant viruses led
to levels of cell-free and cell-associated viruses which peaked at 12 and 24 h p.i., respectively, and ranged from 107 to
109 PFU/ml. In contrast, the kinetics of growth of these
two viruses in J774-1 cells were remarkably different. The 12-h-p.i.
titers of both cell-associated GDVIIL/DAFSSC and DAL*-1 viruses were minimally higher than the 6-h-p.i. titers, gradually decreasing to
approximately 104 PFU/ml at 48 h p.i. This tendency
was even more prominent for cell-free viruses, where there was no
apparent increase of cell-free virus titers but instead steadily
decreasing titers. The results indicated that both GDVIIL/DAFSSC
and DAL*-1 viruses were able to grow in BHK-21 cells but did not
grow in J774-1 cells.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetics of GDVIIL/DAFSSC and DAL*-1 virus growth in
BHK-21 and J774-1 cells. The culture supernatants (solid lines) and
cell lysates (broken lines) of infected BHK-21 or J774-1 cells were
harvested at the indicated times and subjected to titer determination
by a standard plaque assay on BHK-21 cells. Data are expressed as the
mean of three independent experiments. (a) GDVIIL/DAFSSC; (b) DAL*-1.
Details of the construction of these viruses are provided in Materials
and Methods and shown in Fig. 1.
|
|
Viral and cellular protein synthesis of GDVIIL/DAFSSC and DAL*-1
mutant virus following infection of J774-1 cells.
To further
characterize GDVIIL/DAFSSC and DAL*-1 viruses, viral and cellular
protein synthesis was analyzed in J774-1 cells by a pulse-label
experiment. As previously published (14), newly synthesized
virus-specific proteins with some evidence of the shutoff of host
cellular protein were clearly demonstrated 12 h after DA infection
of J774-1 cells (Fig. 4, lane 8) and
there was a remarkable inhibition of both cellular and viral protein synthesis 12 h after GDVII infection of J774-1 cells (lane 9). For
GDVIIL/DAFSSC and DAL*-1 virus infection of J774-1 cells, there was
only a minimum amount of viral protein synthesis throughout the 12-h
period of observation. In addition, no prominent inhibition of cellular
protein synthesis was observed (lanes 2 to 7).

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 4.
Protein synthesis in TMEV-infected J774-1 cells. J774-1
cells infected with GDVIIL/DAFSSC virus (lane 2 to 4) or DAL*-1 virus
(lanes 5 to 7) at various times p.i. were labeled for 3 h with
L-[35S]methionine as described in Materials
and Methods. Lanes: 2 and 5, labeled at 3 h p.i.; 3 and 6, labeled
at 6 h p.i.; 4 and 7, labeled at 9 h p.i.; 8 and 9, DA- and
GDVII-infected J774-1 cells, respectively, labeled at 9 h p.i.; 1, mock-infected J774-1 cells.
|
|
Viral RNA synthesis of DAL*-1 mutant virus following infection of
J774-1 cells.
To examine whether the limited viral growth and
viral protein synthesis occur at the level of viral RNA replication,
viral RNA synthesis of DAL*-1 virus was analyzed by an RNase protection assay and compared with that of the parental DA strain. A
representative gel pattern is shown in Fig.
5. In J774-1 cells infected with the
parental DA strain, viral genomic RNA clearly increased from 3 to
9 h p.i. On the other hand, in J774-1 cells infected with DAL*-1
virus, a decrease of viral genomic RNA was observed from 3 to 9 h.
Similar patterns were also found in several independent experiments
(data not shown). The data suggested that the restriction of
replication of DAL*-1 virus in infection of J774-1 cells occurred at
the step of viral RNA synthesis, as previously reported for the
parental GDVII strain (14).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 5.
Genomic RNA of the parental DA and mutant DAL*-1 viruses
following infection of J774-1 cells. Total RNA was extracted from
J774-1 cells 3 h (lanes 2 and 4) and 9 h (lanes 3 and 5)
after infection of DA (lanes 2 and 3) or DAL*-1 (lanes 4 and 5) virus.
A 10-µg portion of RNA was hybridized with
[ -32P]UTP-labeled riboprobe and treated with RNase
solution. The RNase-resistant fragments were denatured, electrophoresed
on a 5% polyacrylamide-8 M urea gel, and analyzed with a bioimaging
analyzer. Lanes P and 1 contained [ -32P]UTP-labeled
probe and mock-infected J774-1 cells, respectively.
|
|
 |
DISCUSSION |
A number of investigators have attempted to delineate determinants
for the TMEV-induced disease phenotypes. Recent studies have implicated
the L coding region, which is located at the start of the open reading
frame that is used to synthesize the polyprotein and has an unknown
function (19). A previously published study showed that the
L coding region affects virus expression in certain cell types
(8) and indicated the probability that L protein plays a
role in DA-induced demyelinating disease (8). Of interest is
the recent recognition that the L coding region of TO subgroup strains
(DA, BeAn, TO4/WW, and Yale) has an additional alternative, out-of-frame open reading frame starting at the AUG at nt 1079 (7,
13) which synthesizes a 17-kDa protein called L* in vivo and in
vitro (3, 7). In contrast, an ACG rather than an AUG is
present in a genomic region of the virulent GDVII subgroup strains that
corresponds in location to the L* initiation codon of DA (7,
13); therefore, GDVII subgroup strains fail to synthesize L*
protein (7). The importance of L* protein to the late white
matter disease was demonstrated by noting that DAL*-1 virus, which has
a mutation of the DAL* AUG to ACG (but with no change in the
polyprotein coding region), has markedly decreased demyelinating
activity (3).
We previously reported the rather surprising result that GDVII
strain fails to replicate in a murine macrophage-like cell line,
J774-1, while DA productively infects these cells (14). We
were especially interested in this observation because macrophages are
a major site of persistence of TO subgroup strains (1, 5, 9,
12) and because virus persistence is required for DA-induced
demyelinating disease (2, 11).
To identify the determinants for the cell type restriction, we
investigated the growth of a number of recombinant and mutant TMEV
strains in J774-1 cells. GD2C-3'/DAFL3, GD1B-2C/DAFL3, and GD1A-XhoI/DAFL3 viruses grew similarly to the parental DA strain in
J774-1 cells, suggesting that a segment of GDVII from the 1A coding
region to the 3' terminus does not affect virus growth in J774-1 cells.
GDNC/DAFL3 also grew well; however, there was some delay in virus
release. This delay may result from an influence of the GDVII 5'
noncoding region when present in the DA genome. The finding is being
investigated further. On the other hand, GD5'-XhoI/DAFL3 did not grow,
suggesting that a determinant in the DA L coding region is critical for
virus growth in J774-1 cells. This suggestion was confirmed by noting
that growth of GDVIIL/DAFSSC virus, which contains the L coding region
of GDVII substituted for that of DA, is severely restricted in J774-1
cells. Growth in J774-1 cells was also restricted following infection with DAL*-1 virus. Since the only difference in the proteins produced following the parental DA and DAL*-1 virus infections is the synthesis of L* protein, the reason for virus growth in J774-1 cells following infection with the parental DA virus and recombinant viruses that contain the DA L region (which has the L* AUG) is presumably the synthesis of L* protein. In the case of DAL*-1 virus, GDVII virus, and
recombinant viruses that do not contain the DA L region (which lacks
the L* AUG) and do not synthesize L* protein, the growth in J774-1
cells was not observed. We considered further experiments testing the
growth in macrophages of a GDVII mutant virus which contained the L*
AUG. Initial studies, however, suggest that the presence of the L* AUG
within the GDVII genome is not sufficient for the synthesis of L*,
making this approach difficult to pursue. L* protein may play a
critical role in the demyelinating disease because it permits growth in
macrophages with subsequent persistence in these cells, leading to
demyelination.
A previously published study (8) showed that GDVIIL/DAFSSC
and DAL*-1 viruses grew well in BHK-21 cells but required a high MOI
for growth in L-929 cells whereas wild-type DA virus grew well in both
cell lines at high and low MOIs (8). We found that these
viruses grew well in BHK-21 cells but failed to multiply efficiently in
J774-1 cells even at an MOI of 10. These results suggest that the
mechanism for restriction of virus growth in J774-1 cells is different
from that in L-929 cells and/or that the L coding region contains
another determinant(s) for cell-type-specific growth besides L*.
The present study demonstrated that recombinant or mutant TMEV that
does not synthesize the L* protein has a restricted growth in J774-1
cells. On the other hand, DAL*-1 virus does not demonstrate a shutoff
of host cell synthesis in the presence of a minimal production of viral
proteins, as is the case for GDVII virus (14). These
findings suggest that the effects of GDVII infection on the synthesis
of cellular and viral proteins in J774-1 cells are not solely related
to the presence or absence of L* protein.
 |
ACKNOWLEDGMENTS |
This work was supported by a Grant-in-Aid for Scientific Research
from the Ministry of Education, Science, Sports and Culture; a grant
for Project Research from Kanazawa Medical University (P96-1); a grant
from the Japan Health Sciences Foundation; and a grant from the
National Institutes of Health (to R.P.R.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Kanazawa Medical University, Uchinada-machi, Kahoku-gun, Ishikawa 920-0293, Japan. Phone: 81-76-286-2211. Fax: 81-76-286-3961. E-mail: ohara{at}kanazawa-med.ac.jp.
 |
REFERENCES |
| 1.
|
Aubert, C.,
M. Chamorro, and M. Brahic.
1987.
Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease.
Microb. Pathog.
3:319-326[Medline].
|
| 2.
|
Chamorro, M.,
C. Aubert, and M. Brahic.
1986.
Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection.
J. Virol.
57:992-997[Abstract/Free Full Text].
|
| 3.
|
Chen, H.-H.,
W.-P. Kong,
L. Zhang,
P. L. Ward, and R. P. Roos.
1995.
A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease.
Nat. Med.
1:927-931[Medline].
|
| 4.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 5.
|
Clatch, R. J.,
S. D. Miller,
R. Metzner,
M. C. Dal Canto, and H. L. Lipton.
1990.
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).
Virology
176:244-254[Medline].
|
| 6.
|
Fu, J.,
S. Stein,
L. Rosenstein,
T. Bodwell,
M. Routbort,
B. L. Semler, and R. P. Roos.
1990.
Neurovirulence determinants of genetically engineered Theiler viruses.
Proc. Natl. Acad. Sci. USA
87:4125-4129[Abstract/Free Full Text].
|
| 7.
|
Kong, W.-P., and R. P. Roos.
1991.
Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus.
J. Virol.
65:3395-3399[Abstract/Free Full Text].
|
| 8.
|
Kong, W.-P.,
G. D. Ghadge, and R. P. Roos.
1994.
Involvement of cardiovirus leader in host cell-restricted virus expression.
Proc. Natl. Acad. Sci. USA
91:1796-1800[Abstract/Free Full Text].
|
| 9.
|
Levy, M.,
C. Aubert, and M. Brahic.
1992.
Theiler's virus replication in brain macrophages cultured in vitro.
J. Virol.
66:3188-3193[Abstract/Free Full Text].
|
| 10.
|
Lipton, H. L.
1980.
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size.
J. Gen. Virol.
46:169-177[Abstract/Free Full Text].
|
| 11.
|
Lipton, H. L.,
M. Calenoff,
P. Bandyopadhyay,
S. D. Miller,
M. C. Dal Canto,
S. Gerety, and K. Jensen.
1991.
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence.
J. Virol.
65:4370-4377[Abstract/Free Full Text].
|
| 12.
|
Lipton, H. L.,
G. Twaddle, and M. L. Jelachich.
1995.
The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
J. Virol.
69:2525-2533[Abstract].
|
| 13.
|
Michiels, T.,
N. Jarousse, and M. Brahic.
1995.
Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus.
Virology
214:550-558[Medline].
|
| 14.
|
Obuchi, M.,
Y. Ohara,
T. Takegami,
T. Murayama,
H. Takada, and H. Iizuka.
1997.
Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line.
J. Virol.
71:729-733[Abstract].
|
| 15.
|
Ohara, Y., and R. P. Roos.
1987.
The antibody response in Theiler's virus infection: new perspectives on multiple sclerosis.
Prog. Med. Virol.
34:156-179[Medline].
|
| 16.
|
Ohara, Y.,
S. Stein,
J. Fu,
L. Stillman,
L. Klaman, and R. P. Roos.
1988.
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses.
Virology
164:245-255[Medline].
|
| 17.
|
Pevear, D. C.,
J. Borkowski,
M. Calenoff,
C. K. Oh,
B. Ostrowski, and H. L. Lipton.
1988.
Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains.
Virology
165:1-12[Medline].
|
| 18.
|
Roos, R. P.,
S. Stein,
Y. Ohara,
J. Fu, and B. L. Semler.
1989.
Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus.
J. Virol.
63:5492-5496[Abstract/Free Full Text].
|
| 19.
|
Rueckert, R. R.
1996.
Picornaviridae: the viruses and their replication, p. 609-654.
In
B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
|
| 20.
|
Zhang, L.,
A. Senkowski,
B. Shim, and R. P. Roos.
1993.
Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence.
J. Virol.
67:4404-4408[Abstract/Free Full Text].
|
J Virol, June 1998, p. 4950-4955, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Asakura, K., Murayama, H., Himeda, T., Ohara, Y.
(2007). Expression of L* protein of Theiler's murine encephalomyelitis virus in the chronic phase of infection. J. Gen. Virol.
88: 2268-2274
[Abstract]
[Full Text]
-
Takano-Maruyama, M., Ohara, Y., Asakura, K., Okuwa, T.
(2006). Theiler's Murine Encephalomyelitis Virus Leader Protein Amino Acid Residue 57 Regulates Subgroup-Specific Virus Growth on BHK-21 Cells. J. Virol.
80: 12025-12031
[Abstract]
[Full Text]
-
Paul, S., Michiels, T.
(2006). Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness.. J. Gen. Virol.
87: 1237-1246
[Abstract]
[Full Text]
-
Mena, I., Roussarie, J.-P., Brahic, M.
(2004). Infection of Macrophage Primary Cultures by Persistent and Nonpersistent Strains of Theiler's Virus: Role of Capsid and Noncapsid Viral Determinants. J. Virol.
78: 13356-13361
[Abstract]
[Full Text]
-
Asakura, K., Murayama, H., Himeda, T., Ohara, Y.
(2002). Epitope-Tagged L* Protein of Theiler's Murine Encephalomyelitis Virus Is Expressed in the Central Nervous System in the Acute Phase of Infection. J. Virol.
76: 13049-13054
[Abstract]
[Full Text]
-
van Eyll, O., Michiels, T.
(2002). Non-AUG-Initiated Internal Translation of the L* Protein of Theiler's Virus and Importance of This Protein for Viral Persistence. J. Virol.
76: 10665-10673
[Abstract]
[Full Text]
-
van Eyll, O., Michiels, T.
(2000). Influence of the Theiler's Virus L* Protein on Macrophage Infection, Viral Persistence, and Neurovirulence. J. Virol.
74: 9071-9077
[Abstract]
[Full Text]
-
Obuchi, M., Yamamoto, J., Odagiri, T., Uddin, M. N., Iizuka, H., Ohara, Y.
(2000). L* Protein of Theiler's Murine Encephalomyelitis Virus Is Required for Virus Growth in a Murine Macrophage-Like Cell Line. J. Virol.
74: 4898-4901
[Abstract]
[Full Text]
-
Martinat, C., Jarousse, N., Prévost, M.-C., Brahic, M.
(1999). The GDVII Strain of Theiler's Virus Spreads via Axonal Transport. J. Virol.
73: 6093-6098
[Abstract]
[Full Text]